WuXi Biologics Included in S&P Global Sustainability Yearbook for Fourth Consecutive Year

2026-03-02 - 05:36

SHANGHAI, March 2, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has been included in the S&P Global Sustainability Yearbook 2026 (“Yearbook”) in recognition of its strong performance in the 2025 Corporate Sustainability Assessment (CSA). The company was ranked top in its industry and achieved